NFKB1 and neoplasm: Enhancing NF-κB in the TME could potentially shift TAMs from an M2-like state towards a pro-inflammatory M1-like state, thereby reactivating the immune response against the tumor and potentially improving the efficacy of immune-therapies such as anti-PD1.